Medicare Reform Using Part D Model Is Advocacy Priority For PhRMA – Castellani
This article was originally published in The Pink Sheet Daily
Executive Summary
For PhRMA, supporting a move toward privatizing Medicare is a tactic that may help avoid the establishment of new price controls in the system, like the often-discussed mandated drug rebates in Part D.
You may also be interested in...
Romney Advisor Leavitt Champions Part D As Model For Medicare Reform
As the presumptive architect of Republican presidential candidate Mitt Romney’s transition plan, former HHS Secretary Mike Leavitt would be a strong proponent for modeling future Medicare Parts A and B reforms on the Part D program.
CMS Budget Plan: $1 Bil. Increase For Administrative Activities Is New, But Drug Policy Proposals Are Old
CMS budget plan reprises Medicare drug rebates for dual eligibles, eliminating brand/generic patent settlements and other unsuccessful Rx proposals.
PhRMA Hopes To Change Medicare Payment Board Even As It Applauds House-Passed Reform Package
The bill that cleared the House March 21 continues to include creation of an Independent Medicare Advisory Commission with broad powers for implementing cost-cutting measures in Medicare.